A 50?g of protein was incubated in the caspase reaction buffer (25?mM HEPES pH 7.4, 150?mM NaCl, 1?mM EDTA, 0.1% CHAPS, 10% sucrose), 10?mM DTT and containing 5?M of the fluorescent substrate Ac\DEVD\AFC (BD Biosciences) at 37C for 1?h at dark. the action of EV20/MMAF. In mice injected with trastuzumab\resistant HER2+ cells, a single dose of EV20/MMAF MK-2894 sodium salt caused complete and long\lasting tumor regression. Mechanistically, EV20/MMAF bound to cell surface HER3 and became internalized to the lysosomes. Treatment with EV20/MMAF caused cell cycle arrest in mitosis and promoted cell death through mitotic catastrophe. These findings encourage the clinical testing of EV20/MMAF for several indications in MK-2894 sodium salt the HER2+ cancer clinic, including situations in which HER2+ tumors become refractory to approved anti\HER2 therapies. Keywords: breast cancer, drug resistance, HER2, HER3 Subject Categories: Cancer, Chemical Biology This study shows the therapeutic value of EV20/MMAF, a HER3\targeted antibody\drug conjugate loaded with monomethyl auristatin F, for the treatment of breast tumors refractory to conventional anti\HER2 therapies. The paper explained Problem HER2\targeted therapies have revolutionized the therapy of patients bearing HER2+ tumors. Yet, some patients, especially those with advanced disease, may develop resistance to these therapies, underlining the clinical need for alternative treatment strategies. Results In this study, we show that the antibodyCdrug conjugate EV20/MMAF, which targets the cognate receptor HER3, exerts a potent anti\proliferative action on HER2+ breast cancer cells resistant to the conventional anti\HER2 agents trastuzumab, lapatinib, neratinib, and the trastuzumab derivative T\DM1. and tumor growth in BRAF\V600E mutant colon cancer (Prasetyanti resistance to trastuzumab were also sensitive to EV20/MMAF, we explored the effect of trastuzumab on several human HER2+ cells. The criteria for sensitivity or resistance to trastuzumab were established from the responses of BT474 and BTRH cells to the drug (Fig?1A and B). As shown in Fig?2D, SKBR3 cells responded to trastuzumab similarly to wild\type BT474 cells. On the other side, MDA\MB\361, HCC1419, HCC1569, and HCC1954 had a response to trastuzumab similar to that of BTRH cells and Igf1 were therefore considered resistant cells. All the cell lines expressed HER3, in addition to HER2 (Fig?2E), confirming their reported HER2 positivity (Neve microscopy. In BT474 and BTRH cells, fluorescence progressively accumulated intracellularly (Movie EV1 and EV2), demonstrating that pHrodo\EV20/MMAF reached acidic compartments. Moreover, complementary immunofluorescence studies showed colocalization of EV20/MMAF with the lysosomal marker LAMP\1 (Figs?3D and EV3A and B). Finally, to confirm that arrival of the ADC\HER3 complex to the lysosomes promoted its degradation, HER3 levels were analyzed after different treatment times with EV20/MMAF. In BT474 and BTRH cells, treatment with EV20/MMAF caused a decrease in total HER3, which was detectable between 1 and 3?h (Fig?3E and F). In contrast, the antibody did not MK-2894 sodium salt affect the total amount of HER2. Parallel experiments performed with trastuzumab showed that this antibody did not significantly affect the levels of HER2 or HER3 (Fig?EV3C and D). Open in a separate window Figure EV3 Colocalization of EV20/MMAF and LAMP\1, and effect of trastuzumab on HER2 and HER3 levels in BT474 and BTRH cells A Colocalization of EV20/MMAF (10?nM, red) with LAMP1 (green) is shown in white (second row) in BT474 and BTRH cells. Scale bar: 20?m. Colocalization analysis was done with Leica Application Suite Advanced Fluorescence, which generated the MK-2894 sodium salt scatter plots of acquired images (last row). Pure red and green pixels are between abscissa/ordinate and white lines. Colocalizating pixels are found inside the central region of the plot, within the white lines. B Quantitation of the colocalization in 20 photographs, representative of treatment with EV20/MMAF for 0 (black bars) or 24?h (red bars) in BT474 and BTRH cells. Data are represented as mean?+?SD. C Western studies of the.